7,672
Views
4
CrossRef citations to date
0
Altmetric
Editorial

What are the economic barriers of antibiotic R&D and how can we overcome them?

&
Pages 889-892 | Received 26 May 2018, Accepted 21 Aug 2018, Published online: 01 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Majed M Masadeh, Karem H Alzoubi, Majd M Masadeh & Zainah O Aburashed. (2021) Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria. Clinical Pharmacology: Advances and Applications 13, pages 83-90.
Read now
Koippallil Gopalakrishnan Aghila Rani, Mohamad A. Hamad, Dana M. Zaher, Scott McN Sieburth, Navid Madani & Taleb H. Al-Tel. (2021) Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges. Expert Opinion on Drug Discovery 16:4, pages 365-371.
Read now
Thamires Quadros Froes, Bianca Trindade Chaves, Marina Sena Mendes, Rafael Matos Ximenes, Ivanildo Mangueira da Silva, Priscila Brandão Gomes da Silva, Julianna Ferreira Cavalcanti de Albuquerque & Marcelo Santos Castilho. (2021) Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to P. aeruginosa PhzS. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1217-1229.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.